Bonus Replay: How a Biotech Disrupter Is De-risking R&D | Jamey Mock, CFO, Moderna
Nov 27, 2024

Bonus Replay: How a Biotech Disrupter Is De-risking R&D | Jamey Mock, CFO, Moderna

CFO THOUGHT LEADER

Information

Published
November 27, 2024
Type
audio
Language
EN
Author
The Future of Finance is Listening
Categories
businesscareers
Discover
Find new listens